| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 03/17/2011 | US20110065179 Transgene delivering retrovirus targeting collagen exposed at site of tissue injury |
| 03/17/2011 | US20110065174 Hepatitis c virus codon optimized non-structural ns3/4a fusion gene |
| 03/17/2011 | US20110065146 Expression of HIV polypeptides and production of virus-like particles |
| 03/17/2011 | US20110065093 Novel tool for the analysis of neural circuits |
| 03/17/2011 | US20110065091 Coronavirus, Nucleic Acid, Protein, and Methods for the Generation of Vaccine, Medicaments and Diagnostics |
| 03/17/2011 | US20110065089 Novel strain of sars-associated coronavirus and applications thereof |
| 03/17/2011 | US20110064767 Cdna construct of salmonidae alphavirus |
| 03/17/2011 | US20110064764 Attenuated Live Triple G Protein Recombinant Rabies Virus Vaccine for Pre- and Post-Exposure Prophylaxis of Rabies |
| 03/17/2011 | US20110064758 Infectious clones of torque teno virus |
| 03/17/2011 | US20110064697 Hepatitis c virus inhibitors |
| 03/17/2011 | CA2773433A1 Method for the preparation of an influenza virus |
| 03/17/2011 | CA2771908A1 Umbilical cord amniotic membrane products |
| 03/16/2011 | EP2295543A1 Method for the preparation of an influenza virus |
| 03/16/2011 | EP2295542A1 Rescue of influenza virus |
| 03/16/2011 | EP2295023A1 Flavivirus vaccines |
| 03/16/2011 | EP2293804A1 Herpes simplex virus (hsv) with modified tropism, uses and process of preparation thereof |
| 03/16/2011 | EP1694828B1 Serum-free vero cell banking process |
| 03/16/2011 | CN1769433B Recombinant vesicular stomatitis virus and its uses |
| 03/15/2011 | US7906327 Dual expression vector system for antibody expression in bacterial and mammalian cells |
| 03/15/2011 | US7906312 Viral vectors whose replication and, optionally, passenger gene are controlled by a gene switch activated by heat in the presence or absence of a small-molecule regulator |
| 03/15/2011 | US7906311 For production of viruses causing porcine reproductive and respiratory syndrome (PRRS) |
| 03/15/2011 | US7906113 DNA viral vector comprising nucleotide seuences coding modified capsid protein for use in enhancement of heterologous gene transfer; improved exogenous gene expression |
| 03/15/2011 | US7906111 Adeno-associated virus (AAV) clades, sequences, vectors containing same, and uses therefor |
| 03/15/2011 | CA2410297C Assembly of wild-type and chimeric influenza virus-like particles (vlps) |
| 03/10/2011 | WO2011026882A1 Bovine herpesvirus vaccine |
| 03/10/2011 | WO2010148511A8 Chimeric influenza virus-like particles comprising hemagglutinin |
| 03/10/2011 | US20110061136 Fusion protein that directs vaccine antigens to antigen-presenting cells, and applications thereof |
| 03/10/2011 | US20110061120 Self-cleaving ribozymes and uses thereof |
| 03/10/2011 | US20110059513 Efficient cell culture system for hepatitis c virus genotype 1a and 1b |
| 03/10/2011 | US20110059512 Efficient cell culture system for hepatitis c virus genotype 6a |
| 03/10/2011 | US20110059134 Prevention of recurrent viral disease |
| 03/10/2011 | US20110059049 Poxviral oncolytic vectors |
| 03/10/2011 | US20110059040 Compositions and methods for inhibiting viral and bacterial activity |
| 03/10/2011 | US20110059015 Vaccine |
| 03/09/2011 | EP2292802A2 Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses |
| 03/09/2011 | EP2292778A1 Use of lentiviral triplex forming sequences for nuclear transfer of nucleotide sequences |
| 03/09/2011 | EP2292740A1 Phage of Acinetobacter baumannii |
| 03/09/2011 | EP2292739A1 Method for preparing differentiated avian cells and genes involved in the maintenance of pluripotency |
| 03/09/2011 | EP2292262A2 Use of modified novirhabdoviruses to obtain vaccines |
| 03/09/2011 | EP2292245A1 Disinfectant composition comprising phage |
| 03/09/2011 | EP2292097A2 Recombinant parainfluenza virus expression systems and vaccines |
| 03/09/2011 | EP2291517A1 Method of replicating viruses in suspension cultures of dog kidney cells |
| 03/09/2011 | EP2291509A2 Microfluidic isolation of tumor cells or other rare cells from whole blood or other liquids |
| 03/09/2011 | EP1385466B1 Oncolytic virus therapy |
| 03/09/2011 | EP1002066B1 Composition and method for regulating the adhesion of cells and biomolecules to hydrophobic surfaces |
| 03/09/2011 | EP0994949B1 Production of attenuated parainfluenza virus vaccines from cloned nucleotide sequences |
| 03/09/2011 | CN101984061A Vaccine strains of infectious clones of porcine reproductive and respiratory syndrome virus (PRRSV) and application thereof |
| 03/08/2011 | US7901921 Viral purification methods |
| 03/08/2011 | US7901920 Virosome-like-particles |
| 03/08/2011 | US7901919 Chimaeric phages |
| 03/08/2011 | US7901905 Gene expression system based on codon translation efficiency |
| 03/03/2011 | WO2011025179A2 Method of inducing the differentiation of human embryonic stem cells into mesenchymal stem cells |
| 03/03/2011 | WO2011024875A1 Polynucleotide derived from novel hepatitis c virus strain and use thereof |
| 03/03/2011 | US20110053883 Agent that modulates physiological condition of pests, involved in insect c-jun amino-terminal kinase activity |
| 03/03/2011 | US20110053781 Methods and compositions for polypeptide engineering |
| 03/03/2011 | US20110053260 Recombinant poxvirus expressing homologous genes inserted into the poxviral genome |
| 03/03/2011 | US20110053259 Recombinant poxvirus expressing homologous genes inserted into the poxvirus genome |
| 03/03/2011 | US20110053250 Enrichment method of virus |
| 03/03/2011 | US20110053249 Adenoviruses Mutated In The VA Genes For Cancer Treatment |
| 03/03/2011 | US20110053248 Serum-Free Virus Propagation Platform For A Virus Vaccine Candidate |
| 03/03/2011 | US20110053205 Composition and Methods for Expressing Reporter Molecules in Mammalian Cells |
| 03/03/2011 | US20110052634 Attenuated recombinant alphaviruses incapable of replicating in mosquitoes and uses thereof |
| 03/03/2011 | US20110052630 Compositions and Methods Using Herpes Simplex Virus |
| 03/03/2011 | US20110052628 Recombinant Double-Stranded RNA Phage, and Use of the Same |
| 03/03/2011 | US20110052627 Recombinant modified vaccinia virus measles vaccine |
| 03/03/2011 | US20110052626 Leporipoxvirus-derived vaccine vectors |
| 03/03/2011 | US20110052618 Influenza hemagglutinin and neuraminidase variants |
| 03/03/2011 | US20110052585 Compositions and methods for inhibiting interleukin pathways |
| 03/03/2011 | US20110052544 Novel bacteriophage and antibacterial composition comprising the same |
| 03/03/2011 | US20110052543 Novel bacteriophage and antibacterial composition comprising the same |
| 03/03/2011 | US20110052542 Novel bacteriophage and antibacterial composition comprising the same |
| 03/03/2011 | US20110052541 Novel bacteriophage and antibacterial composition comprising the same |
| 03/03/2011 | US20110052539 Oncolytic rhabdovirus |
| 03/03/2011 | CA2769879A1 Polynucleotide derived from novel hepatitis c virus strain and use thereof |
| 03/02/2011 | EP2290109A2 Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses |
| 03/02/2011 | EP2290108A2 Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses |
| 03/02/2011 | EP2290091A2 Recombinant measles viruses expressing epitopes of antigens of RNA viruses and use of the recombinant viruses for the preparation of vaccine compositions |
| 03/02/2011 | EP2290054A1 Alphavirus particles and methods for preparation |
| 03/02/2011 | EP2290053A1 Method for producing Influenza virus in protein-free cell culture medium |
| 03/02/2011 | EP2288693A1 Novel astrovirus |
| 03/02/2011 | EP2288618A1 Chimeric fusion proteins and virus like particles from birnavirus vp2 |
| 03/02/2011 | CN101983238A Method for concentration of virus |
| 03/02/2011 | CN101983069A Influenza hemagglutinin and neuraminidase variants |
| 03/02/2011 | CN101356927B Use of Bdellovibrio in eliminating pathogenicity vibrio in marine products and breeding water body thereof |
| 03/01/2011 | US7897744 SARS virus nucleotide and amino acid sequences and uses thereof |
| 03/01/2011 | US7897381 Uncoupling of DNA insert propagation and expression of protein for phage display |
| 03/01/2011 | US7897343 Propagating attenuated lelystad agent in host cells for use in generating vaccine for prevention and treatment of procine respiratory infection |
| 03/01/2011 | US7897156 Modified vaccinia virus ankara for the vaccination of neonates |
| 03/01/2011 | CA2342203C Method for removal of hiv and other viruses from blood |
| 02/24/2011 | WO2011020530A2 Method for isolating viruses |
| 02/24/2011 | US20110046982 Methods and compositions related to viral inhibition |
| 02/24/2011 | US20110045583 Infectivity-enhanced conditionally-replicative adenovirus and uses thereof |
| 02/24/2011 | US20110045574 Chromatography medium |
| 02/24/2011 | US20110045103 Methods for treating aids |
| 02/24/2011 | US20110045023 Recombinant RSV Virus Expression Systems And Vaccines |
| 02/24/2011 | US20110045020 Nucleic acid comprising chimeric gene derived from hepatitis c virus |
| 02/24/2011 | US20110045019 Porcine torque teno virus vaccines and diagnosis |
| 02/24/2011 | US20110045018 Astrovirus species |
| 02/24/2011 | US20110045016 Utilization of recombinant influenza viruses and modified vaccinia ankara virus (mva) with genes that encode for the toxoplasma gondii sag1 and sag2 surface proteins, as vaccines against toxoplasmosis |
| 02/24/2011 | US20110045013 CAT Allergen Conjugates and Uses Thereof |